The new names on the list are Disney, Discover Financial Services, Emerson Electric and BioMarin Pharmaceutical.

Despite the pandemic, supply-chain woes and rising inflation, things still went right last year for many smart investors.

Recent moves could set pattern for other big and old conglomerates, Real Money's Kevin Curran notes.

Jim Cramer says there are many investors who believe Rivian will become the next Tesla and they're willing to buy in at any price.

Jim Cramer take a look at the stocks he says are poised to profit even when inflation is rising.

Jim Cramer says investors need to give the economy more time. He's not worried about a stagnant economy; he thinks capitalism is the cure.

Aspen Technology, Sofi Technologies, Flexion Therapeutics, Adamas Pharmaceuticals and Ocular Therapeutix are five top stock gainers for Monday.

Emerson will merge its software businesses with smaller rival Aspen Technology in a deal worth around $11 billion, the companies said Monday.

Jim Cramer says it's a tale of two markets. While experienced investors are winning, many in the younger cohort are losing ground.

Apple is asking assemblers to put together 220 million iPhones this year, Bloomberg reported, a tally that largely matches 2021 levels.

"The supply chain continues to be the limiting factor in our production rates but we remain confident in our ability to achieve our target," said CFO Claire McDonough.

DNA-sequencing leader Illumina swung to a loss in Q2 2022. Contributions from Grail didn't help.